Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01420237 · ClinicalTrials.gov registry record · NA
Restoration® Anatomic Dual Mobility (ADM) X3® Acetabular System Study
A NA study, sponsored by Stryker Orthopaedics.
- Terminated
- Registry status
- NA
- Development phase
- 367
- Enrollment target
NCT01420237 is a NA study that was terminated before completion, run by Stryker Orthopaedics. The registered enrollment target is 367 participants.
The verdict
NCT01420237, a NA study, was terminated before completion, sponsored by Stryker Orthopaedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 367 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the success rate of cementless primary hip replacement with the Restoration® ADM X3® Acetabular System as compared to other primary hip systems in the literature, through absence of femoral head dislocation at 10 years postoperative.
Interventions
- DEVICE Restoration ADM X3 Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 367 participants |
| Start Date | 2011-06 |
| Est. Completion | 2023-11-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01420237
The ClinicalTrials.gov registry entry for NCT01420237 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 367 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Restoration ADM X3 Device is the first listed.
NCT01420237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01420237 about?
NCT01420237 is a clinical study titled "Restoration® Anatomic Dual Mobility (ADM) X3® Acetabular System Study". The purpose of this study is to evaluate the success rate of cementless primary hip replacement with the Restoration® ADM X3® Acetabular System as compared to other primary hip systems in the literature, through absence of femoral head dislocation at 10 years postoperative.
What is the current status of trial NCT01420237?
This trial is currently terminated. It is a NA study. The enrollment target is 367 participants. The study started on 2011-06. Estimated completion is 2023-11-09.
What interventions are being tested in trial NCT01420237?
The interventions under investigation include: Restoration ADM X3 Device (DEVICE).
Who is sponsoring clinical trial NCT01420237?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.